Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection

Journal of Hospital Infection

Volumn 78, Issue 4, 2011, Pages 289-292

  Saeed, K ^a   Dryden, M ^a   Bourne, S ^a   Paget, C ^a   Proud, A ^a  

^a ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

Author keywords

Antibiotic stewardship; Biomarker; Collateral damage; Procalcitonin; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DIAGNOSTIC VALUE; DRUG USE; FOLLOW UP; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CALCITONIN; DIAGNOSTIC TESTS, ROUTINE; DRUG UTILIZATION; HUMANS; INTENSIVE CARE; PROTEIN PRECURSORS; TREATMENT OUTCOME;

EID: 79960172958     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.03.018     Document Type: Article

References (31)

1. Carlet J. Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 1999, 13:483-494.
2. Ueda S., Nishio K., Minamino N., et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999, 160:132-136.
3. LaRosa S.P., Opal S.M. Sepsis strategies in development. Clin Chest Med 2008, 29:735-747.
4. Canan B., Hülya S., Ercan G., Sungurtekin U., Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003, 7:85-90.
5. Volante E., Moretti S., Pisani F., Bevilacqua G. Early diagnosis of bacterial infection in the neonate. J Matern Fetal Neonatal Med 2004, 16:13-16.
6. Dryden M., Hand H., Davey P., et al. Antibiotics for community-acquired pneumonia. J Antimicrob Chemother 2009, 64:1123-1125.
7. Santuz P., Soffiati M., Dorizzi R.M., Benedetti M., Zaglia F., Biban P. Procalcitonin for the diagnosis of early-onset neonatal sepsis: a multilevel probabilistic approach. Clin Biochem 2008, 41:1150-1155.
8. Whicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001, 38:483-493.
9. Dandona P., Nix D., Wilson M.F. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79:1605-1608.
10. Christ-Crain M., Muller B. Procalcitonin in bacterial infections - hype, hope, more or less?. Swiss Med Wkly 2005, 135:451-460.
11. Christ-Crain M., Jaccard-Stolz D., Bingisser R. Effect of procalcitonin guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363:600-607.
12. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26:S148-152.
13. Liaudat S., Dayer E., Praz G., Bille J., Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:524-527.
14. Giamarellos-Bourboulis E.J., Mega A., Grecka P. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 2002, 28:1351-1356.
15. Reith H.B., Mittelkötter U., Wagner R., Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000, 26(Suppl 2):S165-169.
16. Rau B.M., Esko A., Kemppainen E.A., et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT). A prospective international multicenter study. Ann Surg 2007, 245:745-754.
17. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G.Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and metaanalysis. Crit Care Med 2006, 34:1996-2003.
18. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohoun C., Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998, 24:185-188.
19. Lapillonne A., Basson E., Monneret G., Bienvenu J., Salle B.L. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 1998, 351:1211-1212.
20. Lanoix J., Bourgeois A., Schmidt J., et al. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus 2011, 20:125-130.
21. Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 1998, 40:1-15.
22. Marshall C., Wolfe R., Kossmann T., Wesselingh S., Harrington G., Spelman D. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hosp Infect 2004, 57:245-252.
23. Proulx N., Fréchette D., Toye B., Chan J., Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. Q J Med 2005, 98:291-298.
24. Iregui M., Ward S., Sherman G., Fraser V.J., Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
25. Mathevon T., Souweine B., Traoré O., Aublet B., Caillaud D. ICU acquired nosocomial infection: impact of delay of adequate antibiotic treatment. Scand J Infect Dis 2002, 34:831-835.
26. Miner J.R., Heegaard W., Mapes A., Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 2001, 21:387-392.
27. Kang C.I., Kim S.H., Kim H.B., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003, 37:745-751.
28. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
29. Larche J., Azoulay E., Fieux F., et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003, 29:1688-1695.
30. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
31. van Zanten A.R., Engelfriet P.M., van Dillen K., et al. Importance of nondrug costs of intravenous antibiotic therapy. Crit Care 2003, 7:R184-190.